| Literature DB >> 35651346 |
Ko Woon Kim1,2,3, Jongdoo Choi4,5, Juhee Chin4,5, Byung Hwa Lee4,5, Duk L Na4,6,7.
Abstract
Visuospatial dysfunction is a common symptom in patients with Alzheimer's disease (AD). To more focus on copying processes rather than on finally completed figures, we conceptually split the copying processes into three stages: visuoperceptual function, visuoconstructional function, and working memory function. We constructed perceptual and working spaces to investigate the different stages of copying, and then, we compared the number and duration of fixations and saccades and the number of switches across the two spaces. We used eye-tracking glasses to assess eye-tracking metrics in patients with early-onset AD (EOAD), patients with late-onset AD (LOAD), and normal control (NC) participants while they copied the simplified Rey-Osterrieth complex figure test (RCFT). Regarding eye metrics on the perceptual space, the number and duration of fixations were greater in both groups of patients with AD than in the NC participants group (number: EOAD vs. NC: p < 0.001, LOAD vs. NC: p = 0. 003/ duration: EOAD vs. NC: p < 0.001, LOAD vs. NC: p < 0.001). On the working space, the number and duration of fixations were greater in the patients with EOAD than in the patients with LOAD and NC participants (number: EOAD vs. LOAD: p = 0. 007, EOAD vs. NC: p = 0. 001/duration: EOAD vs. LOAD: p = 0. 008, EOAD vs. NC: p = 0. 002). The number of saccades and switching was higher in patients with EOAD than in NC participants (p < 0.001). The eye-tracking metrics from the simplified RCFT correlated with the neuropsychological test scores. Patients with EOAD and LOAD achieved the same level of performance at the simplified and original RCFT scores. However, patients with EOAD than LOAD showed a greater number and duration of fixations on the working space and more frequent switching between the perceptual and working spaces, which may reflect more cognitive efforts to achieve the same level of performance.Entities:
Keywords: Alzheimer's disease; Rey–Osterrieth complex figure; copying process; eye-tracking; visuospatial dysfunction
Year: 2022 PMID: 35651346 PMCID: PMC9149280 DOI: 10.3389/fneur.2022.844341
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.086
Clinical information and cognitive profiles.
|
| ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| 64.5(63.0, 67.5) | 78.0 (74.0, 79.0) | 70.0(63.0, 73.0) |
|
| ||
| 61.0 (56.0, 64.0) | 72.0 (69.0, 77.0) | N/A |
| N/A | N/A | |
|
| 12:7 | 12:7 | 7:9 | >0.99 | 0.954 | |
| 10.4 (8.0, 12.0) | 12.0 (12.0, 16.0) | 16.0 (12.0, 16.0) | 0.645 | 0 | ||
|
| 12/18 (66.7%) | 8/19 (42.1%) | 0/12 (0%) | 0.574 | 0 |
|
|
| 17/17 | 7/7 | 0/4 | N/A | N/A | N/A |
|
| ||||||
| Forward digit span (IQR) | 6 (4, 7) | 6 (5, 7) | 7 (6, 8) | >0.99 | 0.058 | |
| Backward digit span (IQR) | 3 (2, 4) | 3 (2, 4) | 5 (4, 7) | >0.99 | 0 |
|
|
| ||||||
| K-BNT (IQR) | 44 (22, 48) | 29 (16, 37) | 54 (49, 57) |
|
|
|
| Calculation (IQR) | 9 (8, 12) | 9 (7, 12) | 12 (12, 12) | >0.99 |
|
|
|
| ||||||
| RCFT: copying (IQR) | 28.0 (12.5, 32.0) | 25.0 (4.5, 29.0) | 35.0 (34.0, 35.5) | 0.966 |
|
|
|
| ||||||
| SVLT: immediate recall (IQR) | 12 (7, 14) | 9 (8, 11) | 24 (21, 26) | 0.812 |
|
|
| SVLT: delayed recall (IQR) | 0 (0, 0) | 0 (0, 0) | 8 (7, 10) | >0.99 |
|
|
| SVLT: recognition (IQR) | 15 (12, 17) | 15 (14, 16) | 23 (22, 24) | >0.99 |
|
|
| RCFT: immediate recall (IQR) | 2.5 (1.0, 3.0) | 0.5 (0.5, 3.0) | 21.5 (15.5, 28.0) | >0.99 |
|
|
| RCFT: delayed recall (IQR) | 0.0 (0.0, 0.0) | 0.0 (0.0, 2.5) | 20.0 (15.5, 27.0) | >0.99 |
|
|
| RCFT: recognition (IQR) | 16.0 (14.0, 17.0) | 15.0 (14.0, 17.5) | 21.5 (20.0, 22.0) | >0.99 |
|
|
|
| ||||||
| COWAT animal (IQR) | 10 (6, 12) | 9 (5, 11)) | 19 (17, 23) | >0.99 |
|
|
| COWAT supermarket (IQR) | 9, (8, 10) | 9 (7, 11) | 19 (15, 23) | >0.99 |
|
|
| COWAT phonemic (IQR) | 13 (11, 20) | 11 (7, 19) | 37 (33, 45) | >0.99 |
|
|
| Stroop test: color (IQR) | 46 (19, 71) | 25 (5, 61) | 111 (86, 112) | >0.99 |
|
|
| 19 (16, 24) | 18 (16, 20) | 30 (29, 30) | >0.99 |
|
| |
| 1.0 (1.0, 1.5) | 1.0 (1.0, 2.0) | 0.5 (0.5, 0.5) | 0.946 |
|
| |
| 5.5 (5.0, 9.5) | 7.0 (5.0, 10.0) | 0.5 (0.5, 0.5) | >0.99 |
|
| |
| 1.5 (1.0, 3.5) | 3.5 (1.0, 7.0) | 1.5 (0.0, 6.0) | >0.99 |
|
| |
Data are presented as the median and IQR (interquartile range) for continuous variables, and the Kruskal–Wallis test and post hoc assessments with Dunn's pairwise tests were used for comparisons.
chi-square test was used to compare categorical variables.
APOE4, apolipoprotein E4; EOAD, early-onset Alzheimer's disease; CDR, Clinical Dementia Rating; COWAT, Controlled Oral Word Association Test; K-BNT, Korean version of the Boston Naming Test; LOAD, late-onset Alzheimer's disease; MMSE, Mini-Mental State Examination; N/A: not accessible; NC, normal control; PET, positron emission tomography; RCFT, Rey–Osterrieth complex figure test; SVLT, Seoul Verbal Learning Test.
APOE4 was analyzed in 49 patients: 18 patients with EOAD, 19 patients with LOAD, and 12 NCs. Participants with one or more copies of the ε4 allele (i.e., ε2/4, ε3/4, ε4/4) were considered to be ε4 carriers (.
Amyloid PET was analyzed in 28 patients: 17 patients with EOAD, 7 patients with LOAD, and 4 NCs. Amyloid PET positivity was interpreted based on the previously reported guidelines for each ligand (.
Statistical analysis of amyloid PET positivity between EOAD vs. LOAD, EOAD vs. NC, and LOAD vs. NC groups were not available because all patients with AD tested positive, and all NC participants tested negative in their amyloid scans.
The italic values show significant differences at P values < 0.05.
Figure 1Drawing from the simplified RCFT and an illustration of eye-tracking metrics. (A) Modified figure from previous publication (39). The simplified RCFT was shown on a tablet computer (size = 12 in, resolution = 2,160 x 1,440, Samsung Galaxy Book 12, Samsung Electronics, Suwon, Korea) with a screen width of 162 mm and a screen height of 258 mm. The upper half was defined as the “perceptual space,” and the lower half was defined as the “working space.” The simplified Rey figure presented in the perceptual space was 152 mm in width and 95 mm in height. The left, right, and upper margins were 30 mm. The blue text, markers, and background colors were not presented to the participants. (B) An illustration of the eye movements made by a normal individual while drawing the simplified RCFT for 15 s. We measured three indices from the eye movements: (1) fixations, (2) saccades, and (3) switches between the two AOIs. The purple circles indicate fixations, and the size of each circle indicates the duration of the fixation. The purple lines connecting the fixations indicate saccades. The red lines across the blue perceptual space and red working space indicate switches between the two spaces. AOI, area of interest; RCFT, Rey–Osterrieth complex figure test.
Eye-tracking metrics.
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
| ||||
|
| |||||||||
| Total number of fixations | 282 (163, 455) | 182 (120, 250) | 118 (98, 146) | 0.314 | 0.219 | 0.724 |
| 0.420 | 0.053 |
| Number of fixations-perceptual AOI | 118 (60, 187) | 67 (50, 121) | 34 (25, 46) | 0.194 | >0.99 | 0.721 |
| 0.613 | 0 |
| Number of fixations-working AOI | 164 (113, 218) | 86 (58, 136) | 81 (69, 105) | 0.474 | 0 | 0.687 |
| 0.047 | >0.99 |
| Ratio (working/perceptual AOI) | 1.47 (1.07, 1.68) | 1.34 (0.47, 2.07) | 2.40 (1.71, 3.59) | 0.125 | >0.99 | 0.608 |
| 0.533 |
|
|
| |||||||||
| Total fixation duration | 105.18 (62.43, 157.40) | 60.07 (43.16, 74.44) | 41.84 (30.38, 52.35) | 0.357 | 0.185 | 0.721 |
| 0.466 | 0 |
| Fixation duration-perceptual AOI | 30.50 (18.13, 56.57) | 17.99 (12.13, 43.48) | 7.22 (5.07, 10.09) | 0.176 | >0.99 | 0.809 |
| 0.720 |
|
| Fixation duration- working AOI | 54.85 (43.88, 79.37) | 31.99 (20.97, 50.17) | 34.58 (22.13, 42.98) | 0.489 | 0 | 0.615 |
| 0.033 | >0.99 |
| Ratio (working/perceptual) | 2.06 (1.37, 2.64) | 1.71 (0.46, 3.21) | 4.84 (3.08, 7.92) | 0.113 | >0.99 | 0.671 |
| 0.633 |
|
|
| |||||||||
| Total number of saccades | 267 (154, 397) | 169 (99, 238) | 105 (85, 137) | 0.298 | 0.200 | 0.712 |
| 0.353 | 0.100 |
| Total duration of saccades (s) | 4.34 (3.75, 4.40) | 3.99 (3.83, 4.46) | 4.32 (3.82, 4.76) | 0.016 | >0.99 | 0.125 | >0.99 | 0.187 | >0.99 |
|
| |||||||||
| Number of switches | 80 (62, 107) | 50 (31, 83) | 36 (30, 47) | 0.373 | 0 | 0.772 |
| 0.267 | 0.227 |
|
| 110.88 (65.09, 167.06) | 64.81 (47. 53, 79.09) | 45.43 (35.28, 58.18) | 0.376 | 0.152 | 0.727 |
| 0.466 | 0 |
Data are presented as the median and IQR (interquartile range) for continuous variables, and the Kruskal–Wallis test and post hoc assessments with Dunn's pairwise tests were used for comparisons. Effect size (r) was calculated with the following formula .
AOI, area of interest; EOAD, early-onset Alzheimer's disease; LOAD, late-onset Alzheimer's disease; NC, normal control.
The italic values show significant differences at P values < 0.05.
Figure 2The number of fixations. (A) Patients with EOAD showed more frequent fixations than NC participants. (B) Patients with EOAD and LOAD showed more frequent fixations on the perceptual space AOI than the NC participants. (C) Patients with EOAD showed more frequent fixations on the working space AOI than the LOAD and NC participants. (D) Patients with EOAD and LOAD showed a higher ratio (working/perceptual space) of fixations on the AOIs than the NC participants. AOI, area of interest; EOAD, early-onset Alzheimer's disease; LOAD, late-onset Alzheimer's disease; NC, normal control. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Figure 3The fixation duration. (A) The total fixations duration was longer in both patient groups with AD than among the NC participants. (B) Patients with EOAD and LOAD showed longer fixation durations on the perceptual space AOI than NC participants. (C) Patients with EOAD showed longer fixation durations on the working space AOI than LOAD and NC participants. (D) Patients with EOAD and LOAD showed a lower ratio (working/perceptual space) of fixation durations on the AOIs than NC participants. AOI, area of interest; EOAD, early-onset Alzheimer's disease; LOAD, late-onset Alzheimer's disease; NC, normal control. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Figure 4Results for saccades and switching. (A) Patients with EOAD showed more frequent saccades than NC participants. (B) Patients with EOAD showed more frequent switching than patients with LOAD and NC participants did. EOAD, early-onset Alzheimer's disease; LOAD, late-onset Alzheimer's disease; NC, normal control. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
The correlation coefficient between eye-tracking metrics and neuropsychological test scores in the combined EOAD and LOAD groups.
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Forward digit span | −0.269 | −0.246 | −0.202 | 0.210 | −0.259 | −0.248 | −0.152 | 0.207 | −0.244 | 0.053 | −0.175 |
| Backward digit span | −0.288 | −0.155 | −0.383 | 0.184 | −0.299 | −0.189 | −0.332 | 0.228 | −0.326 | 0.049 | −0.199 |
| K-BNT | −0.016 | −0.044 | 0.032 | 0.240 | −0.066 | −0.111 | 0.026 | 0.190 | −0.068 | 0.053 | 0.077 |
| Calculation | −0.669 | −0.725 | −0.436 | 0.431 | −0.658 | −0.749 | −0.340 | 0.500 | −0.668 | −0.051 | −0.458 |
| SVLT: immediate recall | 0.020 | 0.099 | −0.110 | 0.107 | −0.007 | 0.058 | −0.087 | 0.164 | −0.092 | −0.106 | −0.152 |
| SVLT: delayed recall | 0.500 | 0.609 | 0.138 | −0.256 | 0.431 | 0.535 | 0.101 | −0.265 | 0.301 | −0.208 | 0.152 |
| SVLT: recognition | 0.038 | 0.166 | −0.175 | −0.034 | 0.034 | 0.145 | −0.148 | 0.027 | −0.065 | −0.197 | −0.117 |
| RCFT: copying | −0.443 | −0.580 | −0.171 | 0.514 | −0.426 | −0.598 | −0.106 | 0.566 | −0.438 | −0.059 | −0.215 |
| RCFT: immediate recall | −0.161 | −0.234 | −0.036 | 0.173 | −0.085 | −0.206 | 0.083 | 0.137 | −0.140 | −0.165 | −0.013 |
| RCFT: delayed recall | −0.059 | −0.094 | −0.004 | 0.041 | 0.010 | −0.065 | 0.101 | 0.027 | −0.053 | −0.235 | 0.018 |
| RCFT: recognition | 0.040 | −0.101 | 0.242 | 0.372 | −0.014 | −0.104 | 0.099 | 0.235 | 0.075 | 0.332 | 0.150 |
| COWAT: animal | −0.291 | −0.276 | −0.204 | 0.408 | −0.342 | −0.320 | −0.233 | 0.365 | −0.359 | 0.000 | −0.162 |
| COWAT: supermarket | −0.322 | −0.289 | −0.250 | 0.382 | −0.349 | −0.337 | −0.224 | 0.432 | −0.387 | −0.021 | −0.263 |
| COWAT: phonemic | −0.417 | −0.365 | −0.338 | 0.321 | −0.395 | −0.368 | −0.258 | 0.375 | −0.416 | −0.041 | −0.300 |
| Stroop test: color | −0.386 | −0.520 | −0.132 | 0.595 | −0.398 | −0.521 | −0.136 | 0.596 | −0.384 | 0.056 | −0.210 |
| MMSE | −0.114 | −0.008 | −0.235 | 0.208 | −0.148 | −0.074 | −0.190 | 0.258 | −0.244 | −0.112 | −0.134 |
p < 0.05.
p < 0.01.
p < 0.001.
AOI, area of interest; COWAT, Controlled Oral Word Association Test; K-BNT, Korean version of the Boston Naming Test; MMSE, Mini-Mental State Examination; RCFT, Rey–Osterrieth complex figure test; SVLT, Seoul Verbal Learning Test.